These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34114100)

  • 21. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
    Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
    J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of the novel coating formulations for skin vaccination using stainless steel microneedle.
    Kim SJ; Shin JH; Noh JY; Song CS; Kim YC
    Drug Deliv Transl Res; 2016 Oct; 6(5):486-97. PubMed ID: 27519363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles vaccination using a microneedle patch.
    Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
    Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-di-GMP with influenza vaccine showed enhanced and shifted immune responses in microneedle vaccination in the skin.
    Shin JH; Lee JH; Jeong SD; Noh JY; Lee HW; Song CS; Kim YC
    Drug Deliv Transl Res; 2020 Jun; 10(3):815-825. PubMed ID: 32141036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
    Nakatsukasa A; Kuruma K; Okamatsu M; Hiono T; Suzuki M; Matsuno K; Kida H; Oyamada T; Sakoda Y
    Vaccine; 2017 May; 35(21):2855-2861. PubMed ID: 28431812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
    Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
    J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
    Hirobe S; Azukizawa H; Hanafusa T; Matsuo K; Quan YS; Kamiyama F; Katayama I; Okada N; Nakagawa S
    Biomaterials; 2015 Jul; 57():50-8. PubMed ID: 25913250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
    Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
    J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
    Fernando GJP; Hickling J; Jayashi Flores CM; Griffin P; Anderson CD; Skinner SR; Davies C; Witham K; Pryor M; Bodle J; Rockman S; Frazer IH; Forster AH
    Vaccine; 2018 Jun; 36(26):3779-3788. PubMed ID: 29779922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.
    Peters EE; Ameri M; Wang X; Maa YF; Daddona PE
    Pharm Res; 2012 Jun; 29(6):1618-26. PubMed ID: 22258935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.
    Littauer EQ; Mills LK; Brock N; Esser ES; Romanyuk A; Pulit-Penaloza JA; Vassilieva EV; Beaver JT; Antao O; Krammer F; Compans RW; Prausnitz MR; Skountzou I
    J Control Release; 2018 Apr; 276():1-16. PubMed ID: 29496540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a thermostable microneedle patch for influenza vaccination.
    Mistilis MJ; Bommarius AS; Prausnitz MR
    J Pharm Sci; 2015 Feb; 104(2):740-9. PubMed ID: 25448542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent.
    Kim YC; Lee JW; Esser ES; Kalluri H; Joyce JC; Compans RW; Skountzou I; Prausnitz MR
    Drug Deliv Transl Res; 2021 Apr; 11(2):692-701. PubMed ID: 33590465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
    Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G
    Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation of microneedles coated with influenza virus-like particle vaccine.
    Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
    AAPS PharmSciTech; 2010 Sep; 11(3):1193-201. PubMed ID: 20676947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.
    Choi HJ; Bondy BJ; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    J Control Release; 2013 Mar; 166(2):159-71. PubMed ID: 23246470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.